Browse the evidence

The agreement (Cohen's κ) between the different combinations of variables used to ascertain sarcopenia status was below .50.

Clinicians should be cautious in interpreting sarcopenia status due to the lack of agreement among assessment methods.

The combination of variables used to ascertain sarcopenia and many of the ALM adjustment techniques have insufficient agreement to be considered equivalent.

A unified definition of sarcopenia is needed for consistent clinical assessment.

To improve the clinical utility of sarcopenia, a unified definition of sarcopenia is required.

Standardizing sarcopenia definitions could lead to better management and treatment outcomes.

There were no significant age-by-resilience interactions found.

Diet quality's impact on resilience appears consistent across different adult age groups.

There is no consistent association between entrée price and Estimated Nutrition Score (ENS) in the sample assessed.

Customers can often choose healthier entrées that are priced less than or equal to less healthy entrées.

More healthy options were more expensive at 2 out of 6 restaurants where a significant association between ENS and price was found.

Practitioners should be aware that not all healthier options are cheaper, as some may be priced higher.

Mean WELL Diet Scores were highest in the oldest age group.

Older adults may benefit from dietary interventions aimed at improving diet quality.

71% of obese individuals, 54% of overweight individuals, and only 10% of underweight individuals are 'very likely' to participate in a weight management program.

Practitioners should focus on targeting overweight and obese military dependents for weight management programs.

The overall prevalence of sarcopenia in the studied population is 6.42%.

Practitioners should be aware of the prevalence of sarcopenia in older adults in urban-rural transition zones.

A long-term farming history is a strong, independent protective factor against sarcopenia.

Encouraging a farming lifestyle may help reduce sarcopenia risk in older adults.

The association between diabetes and sarcopenia was not statistically significant after adjusting for confounders.

Diabetes may not be a significant risk factor for sarcopenia when considering other factors.

Obesity was associated with diabetes only in the urban population.

Urban health initiatives should focus on obesity as a risk factor for diabetes.

Greater weight loss following bariatric surgery correlates with a higher likelihood of discontinuing anti-glycemic medications, although this specific correlation was not statistically significant in this study due to sample size.

While surgery helps everyone, those who lose more weight (11-15 BMI points) are much more likely to stop taking diabetes medications than those who lose less. Aim for significant weight loss to maximize the chance of medication independence.

Skeletal muscle mitochondrial dysfunction and reduced capillary density contribute to early fatigue and reduced peripheral oxygen extraction in T2DM.

Your muscles may have fewer capillaries and less efficient mitochondria, making it harder to use oxygen during exercise. This leads to early fatigue. Resistance and aerobic training can help improve muscle capillary density and mitochondrial function.

Skeletal muscle UCP3 gene expression is negatively correlated with BMI and positively correlated with resting metabolic rate (RMR) in humans, suggesting that reduced UCP3 expression contributes to lower energy expenditure and obesity risk.

Your body's ability to burn energy as heat is partly regulated by genes like UCP3 in your muscles. While you cannot directly 'take' UCP3, understanding that metabolic rate is flexible—and influenced by factors like diet (fasting, fatty acids) and hormones—suggests that metabolic adaptation is possible. Focus on maintaining muscle mass and metabolic health rather than assuming a permanently 'slow' metabolism.

The molecular clock component BMAL1 is required for satellite cell proliferation and the metabolic transition from oxidative to glycolytic energy sources during early muscle regeneration.

BMAL1 acts as a metabolic switch for muscle stem cells. When muscle is damaged, these cells must switch from resting energy (oxidative) to building energy (glycolytic) to multiply. BMAL1 regulates this switch. Disrupting your circadian rhythm (e.g., chronic shift work) might impair this metabolic flexibility, potentially slowing down the initial proliferation phase of muscle repair.

Social determinants of health, specifically poverty and food insecurity, are significant contributors to the high prevalence of obesity in communities of color.

For individuals in communities of color, obesity rates are heavily influenced by systemic factors like poverty and food insecurity. Addressing these social determinants is crucial for effective obesity management, alongside individual lifestyle changes.

Epigenetic priming via nutrient deprivation (caloric restriction) in the F0 generation increases the epigenetic plasticity of subsequent generations, allowing them to better adapt to varying diets and metabolic challenges.

Moderate caloric restriction (e.g., 50-70% of normal intake) during early development or pregnancy may 'prime' the epigenome, making offspring more metabolically resilient to future dietary challenges. However, extreme restriction should be avoided as it can lead to growth issues.

Ketogenic dietary therapies (KDTs) may improve cerebrovascular health and neuroprotection by shifting brain energy metabolism from glucose to ketone bodies (specifically β-hydroxybutyrate), reducing oxidative stress, and modulating inflammatory signaling, though current human evidence is limited and heterogeneous.

If you have cognitive concerns or are aging, a ketogenic diet might offer neuroprotective benefits by shifting your brain's fuel source to ketones, which may reduce inflammation and oxidative stress. However, current human evidence is not strong enough to recommend it broadly. If you try it, consider less restrictive versions like the Modified Atkins Diet for better long-term adherence, and be aware that benefits may take weeks to manifest as your body adapts (keto-adaptation).

Energy restriction inhibits neoplastic progression in animal models, though disentangling the effects of energy restriction from reduced adiposity remains difficult.

While animal studies show energy restriction reduces tumor growth, it is unclear if this is due to the restriction itself or the resulting weight loss. Human studies are needed to clarify this.

Caloric restriction extends lifespan and delays age-related cardiovascular disease by attenuating oxidative stress and activating the Nrf2/antioxidant response element pathway.

To potentially leverage the anti-aging mechanisms described, consider reducing overall caloric intake without malnutrition. This may activate protective pathways like Nrf2 and SIRT1, improving vascular health and reducing oxidative stress. Consult a healthcare provider before making significant dietary changes, especially if you have underlying health conditions.

Pure protein-energy malnutrition (starvation) responds dramatically to nutritional support, unlike cachexia, because the primary mechanism is an energy deficit rather than active catabolic signaling.

If weight loss is due to not eating enough or not absorbing food (malnutrition), providing adequate nutrition will reverse the wasting.

Alternate day fasting does not significantly alter skeletal muscle genes involved in fatty acid transport/oxidation or mitochondrial biogenesis in nonobese humans.

Three weeks of alternate day fasting does not significantly change the expression of genes responsible for fat burning or mitochondrial growth in nonobese people. Your muscle's capacity to oxidize fat may not have increased measurably at the gene level.

Time-restricted eating (TRE) with a 9-hour window (10:00-19:00) does not significantly improve glycaemic control (HbA1c) or reduce body mass in individuals with Type 2 Diabetes compared to habitual eating patterns.

If you have Type 2 Diabetes, simply shifting your eating window to 9 hours (e.g., 10am-7pm) without changing *what* or *how much* you eat will not significantly improve your blood sugar levels or help you lose weight. TRE may be feasible to adhere to, but it is not an effective standalone metabolic intervention for T2D unless it leads to reduced caloric intake.